Bretazenil
≥97%
- Product Code: 54433
CAS:
84379-13-5
| Molecular Weight: | 418.28 g./mol | Molecular Formula: | C₁₉H₂₀BrN₃O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00866987 | |
| Melting Point: | Boiling Point: | 594.3±50.0 °C | |
| Density: | 1.56±0.1 g/cm3 | Storage Condition: | 2-8°C |
Product Description:
Bretazenil is primarily researched for its potential therapeutic applications in the field of neurology and psychiatry. It is being studied as a partial agonist for benzodiazepine receptors, which suggests it could be used in the treatment of anxiety disorders. Unlike full agonists, it may offer a reduced risk of dependency and sedation, making it a candidate for safer anxiolytic medication. Additionally, its properties are being explored for use in managing symptoms of alcohol withdrawal, providing a calming effect without the high potential for abuse associated with other benzodiazepines. Bretazenil is also investigated for its neuroprotective effects, potentially aiding in the treatment of neurodegenerative diseases by protecting neurons from damage. Its ability to modulate GABA receptors without fully activating them positions it as a compound of interest in developing treatments for epilepsy, where it might help control seizures with fewer side effects. Overall, Bretazenil represents a promising avenue for developing safer and more effective treatments for a range of neurological and psychiatric conditions.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | white solid |
| PURITY | 96.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿6,980.00 |
+
-
|
| 0.050 | 10-20 days | ฿16,480.00 |
+
-
|
| 0.250 | 10-20 days | ฿59,800.00 |
+
-
|
Bretazenil
Bretazenil is primarily researched for its potential therapeutic applications in the field of neurology and psychiatry. It is being studied as a partial agonist for benzodiazepine receptors, which suggests it could be used in the treatment of anxiety disorders. Unlike full agonists, it may offer a reduced risk of dependency and sedation, making it a candidate for safer anxiolytic medication. Additionally, its properties are being explored for use in managing symptoms of alcohol withdrawal, providing a calming effect without the high potential for abuse associated with other benzodiazepines. Bretazenil is also investigated for its neuroprotective effects, potentially aiding in the treatment of neurodegenerative diseases by protecting neurons from damage. Its ability to modulate GABA receptors without fully activating them positions it as a compound of interest in developing treatments for epilepsy, where it might help control seizures with fewer side effects. Overall, Bretazenil represents a promising avenue for developing safer and more effective treatments for a range of neurological and psychiatric conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :